Mereo BioPharma (MREO) Other Gross PP&E Adjustments (2022 - 2025)
Mereo BioPharma (MREO) has disclosed Other Gross PP&E Adjustments for 4 consecutive years, with $843000.0 as the latest value for Q3 2025.
- On a quarterly basis, Other Gross PP&E Adjustments rose 127.84% to $843000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $843000.0, a 127.84% increase, with the full-year FY2024 number at -$8.8 million, down 17.32% from a year prior.
- Other Gross PP&E Adjustments was $843000.0 for Q3 2025 at Mereo BioPharma, up from $806000.0 in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $843000.0 in Q3 2025 to a low of -$8.8 million in Q4 2024.
- A 4-year average of -$2.4 million and a median of $230000.0 in 2024 define the central range for Other Gross PP&E Adjustments.
- Peak YoY movement for Other Gross PP&E Adjustments: fell 17.32% in 2024, then soared 636.78% in 2025.
- Mereo BioPharma's Other Gross PP&E Adjustments stood at -$7.9 million in 2022, then rose by 4.36% to -$7.5 million in 2023, then fell by 17.32% to -$8.8 million in 2024, then surged by 109.55% to $843000.0 in 2025.
- Per Business Quant, the three most recent readings for MREO's Other Gross PP&E Adjustments are $843000.0 (Q3 2025), $806000.0 (Q2 2025), and $641000.0 (Q1 2025).